Interview: Nkaki Matlala – Vice-Chairman of the Public Health Enhancement…
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
Working together to enhance health. No single sector in South Africa, whether public or private, can successfully confront the immense challenge of the quadruple burden of disease. It requires combined forces, shared vision and commitment to working together. The Minister of Health officially launched the Social Compact Forum on 8 November 2012. The launch of the Forum was applauded by government and the ANC, as an initiative that leads the way for cooperation between the public and private sectors.
Establishing a social compact in healthcare. To achieve this noble vision the Minister and participating private sector companies established a Social Compact Forum and the Public Health Enhancement Fund (PHEF). The Social Compact Forum which will interact with the Minister and the Public Health Enhancement Fund (PHEF) is a financing instrument established by the Social Compact.
The Public Health Enhancement Fund (PHEF) will be managed by the private sector through the establishment of a not for profit entity in accordance with the Companies Act. Collection and disbursement of funds will be for the benefit of transformative healthcare projects, to be jointly agreed to between the Minister and the private sector. Payments from the fund will be made directly to vendors or, in the case of projects, to the providers of services to the beneficiaries of the projects, as determined by the Board of the PHEF from time to time. The rationale for the fund is for private sectors to contribute in strengthening the health sector and to build trust between the public and private sector. The initiative also aims to leverage the funds within the private sector to maximise benefits for the types of projects envisaged, rather than adopting an individual or silo approach which results in a number of fragmented, smaller projects which do not necessarily have the impact that is required. Ultimately, it is envisaged that this institutionalised engagement will assist in shaping a better future healthcare system for all, regardless of whether they be from the private or public health sector. The funding formula has been developed by corporate lawyers, auditors and BBBEE consultants to ensure that the contributions into the fund are recognised under the Socio-Economic Development (SED) element of the BBBEE balanced scorecard. Empowerdex has confirmed this. The BBBEE Act and its balanced scorecard require companies to spend 1% of Net Profit after tax (NPAT) for maximal SED recognition. The funding formula for the PHEF requires 0,75% for participation in the Fund. This means that participants would contribute 75% of their required SED obligation into the fund. Participation in the initiative comes at no additional cost or earnings dilution, unless companies decide to exceed the 1% NPAT scorecard requirement. Contributing companies stand to benefit from an institutionalised engagement with government, through less fragmentation of SED activities and more efficient channelling of resources.
Contact:
Tel: 011 239 6734
Fax: 011 239 6018
Address:
Building 8, Healthcare Park,
Woodlands Drive, Woodmead, 2191
Web: www.phef.co.za
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
The minister of health reveals how for the first time in the country´s history the healthcare sector is following a clear roadmap with the National Development Plan, a vision for…
The managing director of Southern Medical, Malan de Villiers illustrates the sheer diversity of the company’s current activities and portfolio within South Africa as a leading implant devices company, while…
Charl Louw, Vice President Africa and Middle East at Acelity discusses the challenges of a two-tiered health system for Acelity, the significance of South Africa for the company’s global portfolio…
The managing director of MC Pharma Group, Henk Krebs illustrates how MC Pharma’s new operating structure enables the group to better service its clients, and also highlights the role of…
Ansie Savrda of ERS (pty) ltd, highlights the important role that ERS plays in helping pharmaceutical companies to efficiently navigate South Africa and Africa’s regulatory environment through the company’s broad portfolio of regulatory…
The country manager of Roche Diagnostics SA, Rajen Bhimaraj highlights the current gaps in the country’s healthcare system and elaborates on how the company’s various community initiatives, such as AmpliCare…
The founder and managing director of LT Clinical Research, one of the first wholly black-owned South African CRO, reveals how South Africa is a very conducive environment for CROs, with…
The General Manager of Boehringer Ingelheim South Africa talks about changes that are required to the healthcare system, with far more government/private partnerships, helping to unlock the country´s potential, why…
CEO of the Clicks Group, David Kneale highlights the motivations behind groups involvement in the Public Health Enhancement Fund (PHEF), and also describe the key strategies that have allowed Clicks…
The General Manager of Abbott’s Established Pharmaceuticals Division in South Africa, Gauta Phillip Mavundla illustrates how he is building the division’s presence within the region after the spinoff of AbbVie,…
Muhammad Bodhania, Managing Director of Medreich South Africa discusses potential strategic implications of the recent acquisition of Medreich by Meiji and the importance of local partnerships for global success. Can…
The CEO of BioTech Africa, Jason Lurie, evaluates the domestic and global landscape for diagnostic recombinant proteins, and highlights other developmental streams that have helped diversify the company’s portfolio. He…
See our Cookie Privacy Policy Here